Defunct Company
Total Trials
10
As Lead Sponsor
5
As Collaborator
Total Enrollment
2,932
NCT00974181
The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)
Phase: Phase 3
Role: Collaborator
Start: Jan 31, 2004
Completion: Mar 31, 2010
NCT00165035
Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)
Start: May 31, 2005
Completion: Jul 31, 2011
NCT00322543
Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)
Role: Lead Sponsor
Start: May 31, 2006
Completion: May 31, 2008
NCT00322569
A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)
Start: Jul 31, 2006
Completion: May 31, 2012
NCT00415961
Multi-Center Clinical Trial: Evaluation of Effectiveness and Safety
Phase: N/A
Start: Nov 30, 2006
NCT00422435
CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation
Start: Jan 31, 2007
NCT00440674
Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)
Phase: Phase 4
Start: Feb 28, 2007
Completion: Jul 31, 2009
NCT00993785
CoStar Catheter System Evaluation
Completion: Apr 30, 2008
NCT00606333
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions
Start: Mar 31, 2008
Completion: Oct 31, 2012
NCT00714883
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
Phase: Phase 2
Start: Jun 30, 2008